Creating High-Quality Digital Experiences for ASCO 2022
HIGH-QUALITY DIGITAL EXPERIENCES TO DIFFERENTIATE YOUR BRAND
In-person Booth Experiences
We can create high-resolution digital content to enhance scientific storytelling. Such content can be utilized throughout physical booths on a range of outputs such as:
- Interactive stations
- Augmented reality and immersive experiences
- Holographic displays and more…
Stunning visual content helps attract people to the booth, encouraging further exploration of the scientific messages behind a product, pathway, or mechanism.
We are proud to say we were the first to bring virtual reality content to the world of scientific conferences, and we continue to evolve and innovate our offerings in this space. We are able to adapt interactive augmented reality experiences for large booth installations to help captivate and engage your audience.
HOW WE CAN HELP…
Random42 consists of scientists, artists, animators and programmers, who collaborate to effortlessly intertwine the worlds of science, art and technology, producing some of the most impactful scientific imagery, stories and interactive experiences.
With a unique creative team consisting of both 3D artists and interactive developers, Random42 hosts the collaboration necessary to create the highest quality, cutting-edge experiences.
Our team can create a purpose-built app, seamlessly integrating animations and stunning visuals, allowing the user to interact with molecular structures. Rich stimulating imagery promotes deeper engagement and reinforces the scientific story behind the pharmaceutical product.
ASCO is fast approaching, which is why it is important to act now. The ideal time to begin planning for an event like this is at least 4 months before. Please get in touch as soon as possible if this is something you would like to discuss with us.
WHY IS ASCO SO IMPORTANT?
When ASCO was established over 50 years ago, the founding members wanted an annual meeting to share the latest information about the treatment of cancer as a top priority. This was back in a time when oncology was not yet recognized as a medical specialty.
Since then, ASCO has grown to become one of the most significant biopharma conventions in the industry and one of the largest gatherings of medical professionals in the world. It brings together more than 40,000 doctors, scientists, public officials, patient advocates, investors, and life science executives.
Thousands of scientific abstracts are released in May ahead of the meeting, giving investors an early opportunity to investigate the latest in the oncology drug development field. Many companies will keep their most significant data under wraps, unveiling them as ground-breaking presentations during the conference.